|
[1]
|
Petracci E, Decarli A, Schairer C, et al. Risk factor modification and projections of absolute breast cancer risk[J]. J Natl Cancer Inst, 2011, 103:1037-1048. doi: 10.1093/jnci/djr172 |
|
[2]
|
Sisti JS, Collins LC, Beck AH, et al. Reproductive risk factors in relation to molecular subtypes of breast cancer: Results from the nurses' health studies[J]. Int J Cancer, 2016, 138:2346-2356. doi: 10.1002/ijc.29968 |
|
[3]
|
Bianchini F, Kaaks R, Vainio H. Overweight, obesity, and cancer risk[J]. Lancet Oncol, 2002, 3:565-574. doi: 10.1016/S1470-2045(02)00849-5 |
|
[4]
|
Capasso I, Esposito E, Pentimalli F, et al. Metabolic syndrome affects breast cancer risk in postmenopausal women: National Cancer Institute of Naples experience[J]. Cancer Biol Ther, 2010, 10:1240-1243. doi: 10.4161/cbt.10.12.13473 |
|
[5]
|
Hua X, Wu J, Goldstein JL, et al. Structure of the human gene encoding sterol regulatory element binding protein-1(SREBF1) and localization of SREBF1 and SREBF2 to chromosomes 17p11.2 and 22q13[J]. Genomics, 1995, 25:667-673. doi: 10.1016/0888-7543(95)80009-B |
|
[6]
|
Zelcer N, Hong C, Boyadjian R, et al. LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor[J]. Science, 2009, 325:100-104. doi: 10.1126/science.1168974 |
|
[7]
|
Zhang L, Reue K, Fong LG, et al. Feedback regulation of cholesterol uptake by the LXR-IDOL-LDLR axis[J]. Arterioscler Thromb Vasc Biol, 2012, 32:2541-2546. doi: 10.1161/ATVBAHA.112.250571 |
|
[8]
|
Karuna R, Holleboom AG, Motazacker MM, et al. Plasma levels of 27-hydroxycholesterol in humans and mice with monogenic disturbances of high density lipoprotein metabolism[J]. Atherosclerosis, 2011, 214:448-455. doi: 10.1016/j.atherosclerosis.2010.10.042 |
|
[9]
|
Vrieling A, Buck K, Kaaks R, et al. Adult weight gain in relation to breast cancer risk by estrogen and progesterone receptor status: a meta-analysis[J]. Breast Cancer Res Treat, 2010, 123:641-649. doi: 10.1007/s10549-010-1116-4 |
|
[10]
|
Renehan AG, Roberts DL, Dive C. Obesity and cancer: pathophysiological and biological mechanisms[J]. Arch Physiol Biochem, 2008, 114:71-83. doi: 10.1080/13813450801954303 |
|
[11]
|
Gunter MJ, Xie X, Xue X, et al. Breast cancer risk in metabolically healthy but overweight postmenopausal women[J]. Cancer Res, 2015, 75:270-274. doi: 10.1158/0008-5472.CAN-14-2317 |
|
[12]
|
Hu J, La Vecchia C, de Groh M, et al. Dietary cholesterol intake and cancer[J]. Ann Oncol, 2012, 23:491-500. doi: 10.1093/annonc/mdr155 |
|
[13]
|
Ronco AL, De Stefani E, Stoll M. Hormonal and metabolic modulation through nutrition: towards a primary prevention of breast cancer[J]. Breast, 2010, 19:322-332. doi: 10.1016/j.breast.2010.05.005 |
|
[14]
|
Must A, Spadano J, Coakley EH, et al. The disease burden associated with overweight and obesity[J]. JAMA, 1999, 282:1523-529. doi: 10.1001/jama.282.16.1523 |
|
[15]
|
Howard BV, Ruotolo G, Robbins DC. Obesity and dyslipidemia[J]. Endocrinol Metab Clin North Am, 2003, 32:855-867. doi: 10.1016/S0889-8529(03)00073-2 |
|
[16]
|
Nelson ER, Wardell SE, Jasper JS, et al. 27-Hydroxycholesterol links hypercholes terolemia and breast cancer pathophysiology[J]. Science, 2013, 342:1094-1098. doi: 10.1126/science.1241908 |
|
[17]
|
Pfefferle AD, Herschkowitz JI, Usary J, et al. Transcriptomic classification of genetically engineered mouse models of breast cancer identifies human subtype counterparts[J]. Genome Biol, 2013, 14:R125. http://europepmc.org/abstract/med/24220145 |
|
[18]
|
Llaverias G, Danilo C, Mercier I, et al. Role of cholesterol in the development and progression of breast cancer[J]. Am J Pathol, 2011, 178:402-412. doi: 10.1016/j.ajpath.2010.11.005 |
|
[19]
|
Undela K, Srikanth V, Bansal D. Statin use and risk of breast cancer: a meta-analysis of observational studies[J]. Breast Cancer Res Treat, 2012, 135:261-269. doi: 10.1007/s10549-012-2154-x |
|
[20]
|
Danilo C, Frank PG. Cholesterol and breast cancer development[J]. Curr Opin Pharmacol, 2012, 12:677-682. doi: 10.1016/j.coph.2012.07.009 |
|
[21]
|
Printz C. Researchers find link between high cholesterol and breast cancer[J]. Cancer, 2014, 120:3429. doi: 10.1002/cncr.29110 |
|
[22]
|
Kitahara CM, Berrington de Gonzalez A, Freedman ND, et al. Total cholesterol and cancer risk in a large prospective study in Korea[J]. J Clin Oncol, 2011, 29:1592-1598. doi: 10.1200/JCO.2010.31.5200 |
|
[23]
|
Allott EH, Hursting SD. Obesity and cancer: mechanistic insights from transdisciplinary studies[J]. Endocr Relat Cancer, 2015, 22:R365-R386. http://pubmedcentralcanada.ca/pmcc/articles/PMC4631382/ |
|
[24]
|
Bensinger SJ, Bradley MN, Joseph SB, et al. LXR signaling couples sterol metabolism to proliferation in the acquired immune response[J]. Cell, 2008, 134:97-111. doi: 10.1016/j.cell.2008.04.052 |
|
[25]
|
Alikhani N, Ferguson RD, Novosyadlyy R, et al. Mammary tumor growth and pulmonary metastasis are enhanced in a hyperlipidemic mouse model[J]. Oncogene, 2013, 32:961-967. doi: 10.1038/onc.2012.113 |
|
[26]
|
DuSell CD, McDonnell DP. 27-Hydroxycholesterol: a potential endogenous regulator of estrogen receptor signaling[J]. Trends Pharmacol Sci, 2008, 29:510-514. doi: 10.1016/j.tips.2008.07.003 |
|
[27]
|
DuSell CD, Umetani M, Shaul PW, et al. 27-Hydroxycholesterol is an endogenous selective estrogen receptor modulator[J]. Mol Endocrinol, 2008, 22:65-77. doi: 10.1210/me.2007-0383 |
|
[28]
|
Nelson ER, DuSell CD, Wang X, et al. The oxysterol, 27-hydroxycholesterol, links cholesterol metabolism to bone homeostasis through its actions on the estrogen and liver X receptors[J]. Endocrinology, 2011, 152:4691-4705. doi: 10.1210/en.2011-1298 |
|
[29]
|
Fu X, Menke JG, Chen Y, et al. 27-hydroxycholesterol is an endogenous ligand for liver X receptor in cholesterol-loaded cells[J]. J Biol Chem, 2001, 276:38378-38387. doi: 10.1074/jbc.M105805200 |
|
[30]
|
Corsini A, Maggi FM, Catapano AL. Pharmacology of competitive inhibitors of HMG-CoA reductase[J]. Pharmacol Res, 1995, 31:9-27. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=183c38925252fe17a9fe6de3cc8dc7a6 |
|
[31]
|
Vini R, Juberiya AM, Sreeja S. Evidence of pomegranate methanolic extract in antagonizing the endogenous SERM, 27-hydroxycholesterol[J]. IUBMB Life, 2016, 68:116-121. doi: 10.1002/iub.1465 |
|
[32]
|
Hansson M, Ellis E, Hunt MC, et al. Marked induction of sterol 27-hydroxylase activity and mRNA levels during differentiation of human cultured monocytes into macrophages[J]. Biochim Biophys Acta, 2003, 1593:283-289. doi: 10.1016/S0167-4889(02)00398-1 |
|
[33]
|
Sica A, Larghi P, Mancino A, et al. Macrophage polarization in tumour progression[J]. Semin Cancer Biol, 2008, 18:349-355. doi: 10.1016/j.semcancer.2008.03.004 |
|
[34]
|
Wu Q, Ishikawa T, Sirianni R, et al. 27-Hydroxycholesterol promotes cell-autonomous, ER-positive breast cancer growth[J]. Cell Rep, 2013, 5:637-645. doi: 10.1016/j.celrep.2013.10.006 |
|
[35]
|
Bahl M, Ennis M, Tannock IF, et al. Serum lipids and outcome of early-stage breast cancer: results of a prospective cohort study[J]. Breast Cancer Res Treat, 2005, 94:135-144. doi: 10.1007/s10549-005-6654-9 |
|
[36]
|
Jiralerspong S, Kim ES, Dong W, et al. Obesity, diabetes, and survival outcomes in a large cohort of early-stage breast cancer patients[J]. Ann Oncol, 2013, 24:2506-2514. doi: 10.1093/annonc/mdt224 |
|
[37]
|
Ahern TP, Pedersen L, Tarp M, et al. Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study[J]. J Natl Cancer Inst, 2011, 103:1461-1468. doi: 10.1093/jnci/djr291 |
|
[38]
|
Kwan ML, Habel LA, Flick ED, et al. Post-diagnosis statin use and breast cancer recurrence in a prospective cohort study of early stage breast cancer survivors[J]. Breast Cancer Res Treat, 2008, 109:573-579. doi: 10.1007/s10549-007-9683-8 |
|
[39]
|
Nielsen SF, Nordestgaard BG, Bojesen SE. Statin use and reduced cancer-related mortality[J]. N Engl J Med, 2012, 367:1792-1802. doi: 10.1056/NEJMoa1201735 |
|
[40]
|
Raccosta L, Fontana R, Maggioni D, et al. The oxysterol-CXCR2 axis plays a key role in the recruitment of tumor-promoting neutrophils[J]. J Exp Med, 2013, 210:1711-1728. doi: 10.1084/jem.20130440 |
|
[41]
|
Kaiser J. Cholesterol forges link between obesity and breast cancer[J]. Science, 2013, 342:1028. doi: 10.1126/science.342.6162.1028 |
|
[42]
|
Laisupasin P, Thompat W, Sukarayodhin S, et al. Comparison of serum lipid profiles between normal controls and breast cancer patients[J]. J Lab Physicians, 2013, 5:38-41. doi: 10.4103/0974-2727.115934 |
|
[43]
|
Lee WR, Ishikawa T, Umetani M. The interaction between metabolism, cancer and cardiovascular disease, connected by 27-hydroxycholesterol[J]. Clin Lipidol, 2014, 9:617-624. doi: 10.2217/clp.14.53 |
作者投稿
专家审稿
编辑办公
邮件订阅
RSS
点击查看大图
下载:
